Avatrombopag maleate

Item number	Size	Delivery time	Price
TGM-T68888-25mg	25 mg	7 - 10 business days*	1,520.00€
TGM-T68888-50mg	50 mg	7 - 10 business days*	1,982.00€
TGM-T68888-100mg	100 mg	7 - 10 business days*	2,503.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: Avatrombopag, also known as AKR-501, YM477, AS 1670542 or E5501, is a novel... more

Close menu

Product information "Avatrombopag maleate"

Description: Avatrombopag, also known as AKR-501, YM477, AS 1670542 or E5501, is a novel orally-active thrombopoietin (TPO) receptor agonist. AKR-501 specifically targeted the TPO receptor and stimulated megakaryocytopoiesis throughout the development and maturation of megakaryocytes just as rhTPO did. AKR-501 may be useful in the treatment of patients with thrombocytopenia. Avatrombopag was first approved in 2018. Target: Others. Smiles: OC(=O)\C=C/C(O)=O.OC(=O)C1CCN(CC1)c1ncc(cc1Cl)C(=O)Nc1nc(-c2cc(Cl)cs2)c(s1)N1CCN(CC1)C1CCCCC1

Supplier:	TargetMol
Supplier-Nr:	T68888

Properties

Application:	Targets thrombopoietin receptor (TPOR, MPL, CD110)
MW:	765.72 D
Formula:	C33H38Cl2N6O7S2

Database Information

CAS :	677007-74-8\| Matching products
KEGG ID :	K05082 \| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "Avatrombopag maleate"

Write a review